Cytology

The CINtec Plus test complements liquid-based cytology (LBC). It reveals concerning changes where routine cytological testing may not have provided sufficient information.

Test Package Consisting of: CINtec PLUS p16/Ki67, Liquid-Based Cytology (LBC), HPV14.

Test Package Consisting of: CINtec PLUS p16/Ki67 – A test performed to deepen the diagnosis of precancerous changes and cervical cancer, Liquid-Based Cytology (LBC): A more modern and precise cytological examination technique, HPV14: Identification of 14 HPV genotypes (Human Papilloma Virus).

Simultaneous detection and genotyping of 28 different high- and low-risk HPV genotypes associated with the development of cervical cancer.

Thin-layer cytology (LBC) combined with HPV testing is the best method for detecting precancerous changes and cervical cancer. The additional qualitative test covering 14 high-risk HPV genotypes detects the most common high-risk types.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genitalóinfections caused by Mycoplasma hominis.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while allowing to confirm or exclude the existence of genital infections caused by Mycoplasma genitalium.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while also allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Ureaplasma sp., Mycoplasma genitalium, M.hominis, HSV, HPV.

It is a gynecological screening test to detect precancerous lesions and cervical cancer, while also allowing to confirm or exclude the existence of genital infections caused by Chlamydia trachomatis, Ureaplasma sp., Mycoplasma genitalium, M.hominis, HPV.